These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29716394)

  • 1. Novel Biomarkers for Coronary Restenosis Occurrence After Drug-Eluting Stent Implantation in Patients With Diabetes Having Stable Coronary Artery Disease.
    Gabbasov Z; Kozlov S; Melnikov I; Byazrova S; Saburova O; Prokofieva L; Caprnda M; Curilla E; Gaspar L; Rodrigo L; Kruzliak P; Smirnov V
    Clin Appl Thromb Hemost; 2018 Nov; 24(8):1308-1314. PubMed ID: 29716394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood level of CD45+ platelets and development of restenosis after drug-eluting stent implantation in patients with stable coronary artery disease.
    Gabbasov Z; Kozlov S; Byazrova S; Saburova O; Melnikov I; Caprnda M; Curilla E; Gaspar L; Kruzliak P; Smirnov V
    Wien Klin Wochenschr; 2016 Dec; 128(23-24):898-905. PubMed ID: 27637207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remnant Lipoprotein Cholesterol Independently Associates With In-Stent Restenosis After Drug-Eluting Stenting for Coronary Artery Disease.
    Xu X; Pandit RU; Han L; Li Y; Guo X
    Angiology; 2019 Oct; 70(9):853-859. PubMed ID: 31167539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrity(®) bare-metal coronary stent-induced platelet and endothelial cell activation results in a higher risk of restenosis compared to Xience(®) everolimus-eluting stents in stable angina patients.
    Szük T; Fejes Z; Debreceni IB; Kerényi A; Édes I; Kappelmayer J; Nagy B
    Platelets; 2016 Jul; 27(5):410-9. PubMed ID: 26765134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum resistin as a biological marker for coronary artery disease and restenosis in type 2 diabetic patients.
    On YK; Park HK; Hyon MS; Jeon ES
    Circ J; 2007 Jun; 71(6):868-73. PubMed ID: 17526982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients).
    Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Hong MK; Kim HS; Ko JK; Park JH; Lee JH; Choi SW; Seong IW; Cho YH; Lee NH; Kim JH; Chun KJ; Park SJ
    J Am Coll Cardiol; 2008 Mar; 51(12):1181-7. PubMed ID: 18355656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prediction model based on platelet parameters, lipid levels, and angiographic characteristics to predict in-stent restenosis in coronary artery disease patients implanted with drug-eluting stents.
    Gai MT; Zhu B; Chen XC; Liu F; Xie X; Gao XM; Ma X; Fu ZY; Ma YT; Chen BD
    Lipids Health Dis; 2021 Sep; 20(1):118. PubMed ID: 34587955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up.
    Zhao LP; Xu WT; Wang L; Li H; Shao CL; Gu HB; Chan SP; Xu HF; Yang XJ
    Coron Artery Dis; 2015 Jan; 26(1):5-10. PubMed ID: 25211654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of pre-operative circulating inflammatory cytokines with restenosis and rapid angiographic stenotic progression risk in coronary artery disease patients underwent percutaneous coronary intervention with drug-eluting stents.
    Sun J; Yu H; Liu H; Pu D; Gao J; Jin X; Liu X; Yan A
    J Clin Lab Anal; 2020 Mar; 34(3):e23108. PubMed ID: 31729103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between the Level of Circulating CD45
    Gabbasov ZA; Kozlov SG; Byazrova SV; Mel'nikov IS; Saburova OS
    Bull Exp Biol Med; 2017 Feb; 162(4):524-527. PubMed ID: 28243907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The CD45-positive thrombocytes and neutrophils/lymphocytes level ratio in evaluation of risk of development of re-stenosis шт patients with chronic ischemic heart disease and diabetes mellitus type II.].
    Gabbasov ZA; Kozlov SG; Melnikov IS; Byazrova SV; Saburova OS; Prokofieva LV
    Klin Lab Diagn; 2018; 63(4):233-238. PubMed ID: 30677279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictor of in-stent restenosis in patients with drug-eluting stent (PRIDE)- a retrospective cohort study.
    Gupta PK; Balachander J
    Clin Investig Arterioscler; 2021; 33(4):184-194. PubMed ID: 33622608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry).
    Fröbert O; Lagerqvist B; Carlsson J; Lindbäck J; Stenestrand U; James SK
    J Am Coll Cardiol; 2009 May; 53(18):1660-7. PubMed ID: 19406341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated Levels of Very Low-density Lipoprotein Cholesterol Independently Associated with In-stent Restenosis in Diabetic Patients after Drug-eluting Stent Implantation.
    Qin Z; Zheng FW; Zeng C; Zhou K; Geng Y; Wang JL; Li YP; Ji QW; Zhou YJ
    Chin Med J (Engl); 2017 Oct; 130(19):2326-2332. PubMed ID: 28836572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of preprocedural levels of advanced glycation end products to predict restenosis in patients with controlled diabetes mellitus undergoing drug-eluting stent implantation for stable angina pectoris (from the Prospective ARMYDA-AGEs Study).
    Spadaccio C; Patti G; De Marco F; Coccia R; Di Domenico F; Pollari F; Zanzonico R; Pettinari M; Lusini M; Di Sciascio G; Covino E; Chello M
    Am J Cardiol; 2013 Jul; 112(1):21-6. PubMed ID: 23561587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of peripheral blood eosinophil count in predicting in-stent restenosis in patients with stable angina pectoris undergoing drug eluting stenting.
    Hajizadeh R; Ghaffari S; Separham A; Shokouhi B; Kavandi H; Pourafkari L; Nader ND
    Rom J Intern Med; 2017 Dec; 55(4):229-236. PubMed ID: 28672766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary in-stent restenosis in diabetic patients after implantation of sirolimus or paclitaxel drug-eluting coronary stents.
    Kitoga M; Pasquet A; Preumont V; Kefer J; Hermans MP; Vanoverschelde JL; Buysschaert M
    Diabetes Metab; 2008 Feb; 34(1):62-7. PubMed ID: 18069029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the Endothelial Nitric Oxide Synthase Gene T786C Polymorphism with In-Stent Restenosis in Chinese Han Patients with Coronary Artery Disease Treated with Drug-Eluting Stent.
    Zeng WP; Zhang R; Li R; Luo JF; Hu XF
    PLoS One; 2017; 12(1):e0170964. PubMed ID: 28129392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do pre-procedural laboratory parameters predict drug-eluting stent restenosis?
    Tanındı A; Ekici B; Töre HF
    Turk Kardiyol Dern Ars; 2015 Jul; 43(5):457-64. PubMed ID: 26148078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.